Krystal Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. 

CEO
Krish S. Krishnan
CEOKrish S. Krishnan
Employees
295
Employees295
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2016
Founded2016
Employees
295
Employees295

KRYS Key Statistics

Market cap
7.65B
Market cap7.65B
Price-Earnings ratio
38.28
Price-Earnings ratio38.28
Dividend yield
Dividend yield
Average volume
363.51K
Average volume363.51K
High today
$264.03
High today$264.03
Low today
$252.61
Low today$252.61
Open price
$261.51
Open price$261.51
Volume
319.03K
Volume319.03K
52 Week high
$298.30
52 Week high$298.30
52 Week low
$122.80
52 Week low$122.80

Stock Snapshot

With a market cap of 7.65B, Krystal Biotech(KRYS) trades at $261.80. The stock has a price-to-earnings ratio of 38.28.

During the trading session on 2026-02-23, Krystal Biotech(KRYS) shares reached a daily high of $264.03 and a low of $252.61. At a current price of $261.80, the stock is +3.6% higher than the low and still -0.8% under the high.

Trading volume for Krystal Biotech(KRYS) stock has reached 319.03K, versus its average volume of 363.51K.

The stock's 52-week range extends from a low of $122.80 to a high of $298.30.

The stock's 52-week range extends from a low of $122.80 to a high of $298.30.

KRYS News

Simply Wall St 4d
Is Krystal Biotech Priced Right After A 61% One-Year Share Gain?

If you are wondering whether Krystal Biotech's share price reflects its true worth, this article will walk through how the current market price compares with a...

Is Krystal Biotech Priced Right After A 61% One-Year Share Gain?
TipRanks 5d
Krystal Biotech Earnings Call Highlights Profitable Growth

Krystal Biotech, Inc. ((KRYS)) has held its Q4 earnings call. Read on for the main highlights of the call. President's Day Sale - 70% Off Unlock hedge fund-leve...

The Motley Fool 6d
Krystal Biotech Q4 2025 Earnings Transcript

Image source: The Motley Fool. Tuesday, Feb. 17, 2026 at 8:30 a.m. ET Call participants Vice President of Corporate Development — Stephane Paquette Chairman an...

Krystal Biotech Q4 2025 Earnings Transcript

Analyst ratings

100%

of 11 ratings
Buy
100%
Hold
0%
Sell
0%

More KRYS News

TipRanks 6d
Krystal Biotech reports Q4 EPS $1.70, consensus $1.61

Reports Q4 revenue $107.1M, consensus $105.13M. “In 2025, Krystal made meaningful progress on our mission to serve patients with dystrophic epidermolysis bullos...

The Motley Fool 7d
Got $300? 2 Biotech Stocks to Buy and Hold Forever

These two biotechs only have one marketable therapy each, but both have blockbuster potential. Krystal Biotech (KRYS +2.58%) and ARS Pharmaceuticals (SPRY +0.6...

Got $300? 2 Biotech Stocks to Buy and Hold Forever

People also own

Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.